Related Experiment Videos
Imaging tumor hypoxia and tumor perfusion
D Groshar1, A J McEwan, M B Parliament
1Cross Cancer Institute, Edmonton, Alberta, Canada.
Summary
Nuclear medicine imaging reveals that reduced tumor perfusion correlates with increased hypoxia. This finding, using technetium-99m hexamethylpropyleneamine oxime and iodine-123 iodoazomycin arabinoside, has implications for cancer treatment strategies.
Area of Science:
- Oncology
- Nuclear Medicine
- Medical Imaging
Background:
- Tumor perfusion and oxygenation are critical factors influencing cancer treatment outcomes.
- Novel nuclear medicine probes for assessing tumor perfusion and hypoxia have been developed.
Purpose of the Study:
- To measure tumor perfusion and oxygenation status using specific nuclear medicine probes.
- To investigate the correlation between perfusion and hypoxia in various cancer types.
Main Methods:
- Utilized technetium-99m hexamethylpropyleneamine oxime (99mTc-HMPAO) for perfusion assessment.
- Employed iodine-123 iodoazomycin arabinoside (123I-IAZA) for hypoxia evaluation.
- Analyzed data from 27 tumors in 22 patients.
Main Results:
- An inverse correlation was observed between 99mTc-HMPAO uptake (perfusion) and 123I-IAZA uptake (hypoxia) (p < 0.05).
- Severe perfusion deficits were typically associated with increased hypoxia markers.
- This trend was consistent across several cancer types, excluding glioblastoma multiforme.
Conclusions:
- Combined use of perfusion and hypoxia imaging agents provides valuable physiological tumor information.
- These imaging modalities can potentially guide cancer therapy decisions.
- Understanding tumor microenvironment through imaging is crucial for personalized treatment approaches.